0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Antiserum Market Research Report 2026
Published Date: 2026-04-18
|
Report Code: QYRE-Auto-10V3651
Home | Market Reports | Business & Industrial| Chemicals Industry
Global Antiserum Market Insights Forecast to 2028
BUY CHAPTERS

Global Antiserum Market Research Report 2026

Code: QYRE-Auto-10V3651
Report
2026-04-18
Pages:119
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Antiserum Market Size

The global Antiserum market was valued at US$ 1618 million in 2025 and is anticipated to reach US$ 2555 million by 2032, at a CAGR of 6.8% from 2026 to 2032.

Antiserum Market

Antiserum Market

Antiserum, a type of blood serum that contains specific antibodies against an antigen (foreign agent), such as an infective organism or poisonous substance. Antibodies in antiserum work by detecting and subsequently neutralizing antigens. Antiserums are produced in animals, most commonly horses, sheep, oxen, and rabbits, and in humans, in response to infection, intoxication, or vaccination. Animal and human antiserums can be used in other individuals to confer immunity to a specific disease or to treat bites or stings of venomous animals. Antiserum widely used in diagnostic virology laboratories. The most common use of antiserum in humans is as antitoxin or antivenom to treat envenomation.
The Antiserum market belongs to the pharmaceutical industry, and its development is closely related to economic development and people's quality of life. Antiserum is used in the treatment of snake venom, rabies, tetanus, etc. and bacterial detection. The market potential is huge. Policy support and emphasis on food and water safety are the main factors promoting market development.
Product safety risks, high industry barriers, high safety requirements, and stricter market regulation are the main factors hindering market development.
In terms of regional development, at present, the sources of market supply are mainly concentrated in North America. With the technological development and progress of Asian countries, in the future, we can focus on the development trend of Asian regions.
In terms of market competition, due to the higher technical barriers and stricter regulation of biopharmaceuticals, the market competition is relatively mild.
The major global companies of Antiserum include CSL,Merck,BTG,Pfizer,CNBG and etc. The top five vendors held 59% of the market.
In the future, with the continuous development of the market and the increase of new entrants, relevant companies need to fully promote the clinical research and preclinical research of new products, and at the same time continue to research and explore, and strive to achieve technological innovation and breakthroughs in existing products and improve product quality compete with safe, effective, economical and suitable product differentiation, and avoid being eliminated by the continuously developing market.
This report delivers a comprehensive overview of the global Antiserum market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Antiserum. The Antiserum market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Antiserum market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Antiserum manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Antiserum Market Report

Report Metric Details
Report Name Antiserum Market
Accounted market size in 2025 US$ 1618 million
Forecasted market size in 2032 US$ 2555 million
CAGR 6.8%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Antitoxin Serum
  • Antibacterial Serum
  • Antiviral Serum
  • Others
Segment by Application
  • Clinical
  • Laboratory
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company CSL, Merck, BTG, Pfizer, CNBG, Bharat Serums and Vaccines, Haffkine Bio-Pharmaceutical, Serum Biotech, Bio-Rad, BD, Vins Bioproducts, FUJIFILM Wako Pure Chemical Corporation, SSI Diagnostica, GD Animal Health
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
  • Chapter 3: Provides a detailed view of the competitive landscape for Antiserum companies, covering revenue share, development plans, and mergers and acquisitions.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
  • Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
  • Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
  • Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
  • Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is Antiserum Market growing?

Ans: The Antiserum Market witnessing a CAGR of 6.8% during the forecast period 2026-2032.

What is the Antiserum Market size in 2032?

Ans: The Antiserum Market size in 2032 will be US$ 2555 million.

Who are the main players in the Antiserum Market report?

Ans: The main players in the Antiserum Market are CSL, Merck, BTG, Pfizer, CNBG, Bharat Serums and Vaccines, Haffkine Bio-Pharmaceutical, Serum Biotech, Bio-Rad, BD, Vins Bioproducts, FUJIFILM Wako Pure Chemical Corporation, SSI Diagnostica, GD Animal Health

What are the Application segmentation covered in the Antiserum Market report?

Ans: The Applications covered in the Antiserum Market report are Clinical, Laboratory

What are the Type segmentation covered in the Antiserum Market report?

Ans: The Types covered in the Antiserum Market report are Antitoxin Serum, Antibacterial Serum, Antiviral Serum, Others

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Antiserum Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Antitoxin Serum
1.2.3 Antibacterial Serum
1.2.4 Antiviral Serum
1.2.5 Others
1.3 Market by Application
1.3.1 Global Antiserum Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Clinical
1.3.3 Laboratory
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Antiserum Market Perspective (2021–2032)
2.2 Global Antiserum Growth Trends by Region
2.2.1 Global Antiserum Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Antiserum Historic Market Size by Region (2021–2026)
2.2.3 Antiserum Forecasted Market Size by Region (2027–2032)
2.3 Antiserum Market Dynamics
2.3.1 Antiserum Industry Trends
2.3.2 Antiserum Market Drivers
2.3.3 Antiserum Market Challenges
2.3.4 Antiserum Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Antiserum Players by Revenue
3.1.1 Global Top Antiserum Players by Revenue (2021–2026)
3.1.2 Global Antiserum Revenue Market Share by Players (2021–2026)
3.2 Global Top Antiserum Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Antiserum Revenue
3.4 Global Antiserum Market Concentration Ratio
3.4.1 Global Antiserum Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Antiserum Revenue in 2025
3.5 Global Key Players of Antiserum Head Offices and Areas Served
3.6 Global Key Players of Antiserum, Products and Applications
3.7 Global Key Players of Antiserum, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Antiserum Breakdown Data by Type
4.1 Global Antiserum Historic Market Size by Type (2021–2026)
4.2 Global Antiserum Forecasted Market Size by Type (2027–2032)
5 Antiserum Breakdown Data by Application
5.1 Global Antiserum Historic Market Size by Application (2021–2026)
5.2 Global Antiserum Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Antiserum Market Size (2021–2032)
6.2 North America Antiserum Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Antiserum Market Size by Country (2021–2026)
6.4 North America Antiserum Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Antiserum Market Size (2021–2032)
7.2 Europe Antiserum Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Antiserum Market Size by Country (2021–2026)
7.4 Europe Antiserum Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Antiserum Market Size (2021–2032)
8.2 Asia-Pacific Antiserum Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Antiserum Market Size by Region (2021–2026)
8.4 Asia-Pacific Antiserum Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Antiserum Market Size (2021–2032)
9.2 Latin America Antiserum Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Antiserum Market Size by Country (2021–2026)
9.4 Latin America Antiserum Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Antiserum Market Size (2021–2032)
10.2 Middle East & Africa Antiserum Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Antiserum Market Size by Country (2021–2026)
10.4 Middle East & Africa Antiserum Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 CSL
11.1.1 CSL Company Details
11.1.2 CSL Business Overview
11.1.3 CSL Antiserum Introduction
11.1.4 CSL Revenue in Antiserum Business (2021–2026)
11.1.5 CSL Recent Development
11.2 Merck
11.2.1 Merck Company Details
11.2.2 Merck Business Overview
11.2.3 Merck Antiserum Introduction
11.2.4 Merck Revenue in Antiserum Business (2021–2026)
11.2.5 Merck Recent Development
11.3 BTG
11.3.1 BTG Company Details
11.3.2 BTG Business Overview
11.3.3 BTG Antiserum Introduction
11.3.4 BTG Revenue in Antiserum Business (2021–2026)
11.3.5 BTG Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Details
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Antiserum Introduction
11.4.4 Pfizer Revenue in Antiserum Business (2021–2026)
11.4.5 Pfizer Recent Development
11.5 CNBG
11.5.1 CNBG Company Details
11.5.2 CNBG Business Overview
11.5.3 CNBG Antiserum Introduction
11.5.4 CNBG Revenue in Antiserum Business (2021–2026)
11.5.5 CNBG Recent Development
11.6 Bharat Serums and Vaccines
11.6.1 Bharat Serums and Vaccines Company Details
11.6.2 Bharat Serums and Vaccines Business Overview
11.6.3 Bharat Serums and Vaccines Antiserum Introduction
11.6.4 Bharat Serums and Vaccines Revenue in Antiserum Business (2021–2026)
11.6.5 Bharat Serums and Vaccines Recent Development
11.7 Haffkine Bio-Pharmaceutical
11.7.1 Haffkine Bio-Pharmaceutical Company Details
11.7.2 Haffkine Bio-Pharmaceutical Business Overview
11.7.3 Haffkine Bio-Pharmaceutical Antiserum Introduction
11.7.4 Haffkine Bio-Pharmaceutical Revenue in Antiserum Business (2021–2026)
11.7.5 Haffkine Bio-Pharmaceutical Recent Development
11.8 Serum Biotech
11.8.1 Serum Biotech Company Details
11.8.2 Serum Biotech Business Overview
11.8.3 Serum Biotech Antiserum Introduction
11.8.4 Serum Biotech Revenue in Antiserum Business (2021–2026)
11.8.5 Serum Biotech Recent Development
11.9 Bio-Rad
11.9.1 Bio-Rad Company Details
11.9.2 Bio-Rad Business Overview
11.9.3 Bio-Rad Antiserum Introduction
11.9.4 Bio-Rad Revenue in Antiserum Business (2021–2026)
11.9.5 Bio-Rad Recent Development
11.10 BD
11.10.1 BD Company Details
11.10.2 BD Business Overview
11.10.3 BD Antiserum Introduction
11.10.4 BD Revenue in Antiserum Business (2021–2026)
11.10.5 BD Recent Development
11.11 Vins Bioproducts
11.11.1 Vins Bioproducts Company Details
11.11.2 Vins Bioproducts Business Overview
11.11.3 Vins Bioproducts Antiserum Introduction
11.11.4 Vins Bioproducts Revenue in Antiserum Business (2021–2026)
11.11.5 Vins Bioproducts Recent Development
11.12 FUJIFILM Wako Pure Chemical Corporation
11.12.1 FUJIFILM Wako Pure Chemical Corporation Company Details
11.12.2 FUJIFILM Wako Pure Chemical Corporation Business Overview
11.12.3 FUJIFILM Wako Pure Chemical Corporation Antiserum Introduction
11.12.4 FUJIFILM Wako Pure Chemical Corporation Revenue in Antiserum Business (2021–2026)
11.12.5 FUJIFILM Wako Pure Chemical Corporation Recent Development
11.13 SSI Diagnostica
11.13.1 SSI Diagnostica Company Details
11.13.2 SSI Diagnostica Business Overview
11.13.3 SSI Diagnostica Antiserum Introduction
11.13.4 SSI Diagnostica Revenue in Antiserum Business (2021–2026)
11.13.5 SSI Diagnostica Recent Development
11.14 GD Animal Health
11.14.1 GD Animal Health Company Details
11.14.2 GD Animal Health Business Overview
11.14.3 GD Animal Health Antiserum Introduction
11.14.4 GD Animal Health Revenue in Antiserum Business (2021–2026)
11.14.5 GD Animal Health Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Antiserum Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
 Table 2. Key Players of Antitoxin Serum
 Table 3. Key Players of Antibacterial Serum
 Table 4. Key Players of Antiviral Serum
 Table 5. Key Players of Others
 Table 6. Global Antiserum Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
 Table 7. Global Antiserum Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 8. Global Antiserum Market Size by Region (US$ Million), 2021–2026
 Table 9. Global Antiserum Market Share by Region (2021–2026)
 Table 10. Global Antiserum Forecasted Market Size by Region (US$ Million), 2027–2032
 Table 11. Global Antiserum Market Share by Region (2027–2032)
 Table 12. Antiserum Market Trends
 Table 13. Antiserum Market Drivers
 Table 14. Antiserum Market Challenges
 Table 15. Antiserum Market Restraints
 Table 16. Global Antiserum Revenue by Players (US$ Million), 2021–2026
 Table 17. Global Antiserum Market Share by Players (2021–2026)
 Table 18. Global Top Antiserum Players by Tier (Tier 1, Tier 2, and Tier 3), based on Antiserum Revenue, 2025
 Table 19. Ranking of Global Top Antiserum Companies by Revenue (US$ Million) in 2025
 Table 20. Global 5 Largest Players Market Share by Antiserum Revenue (CR5 and HHI), 2021–2026
 Table 21. Global Key Players of Antiserum, Headquarters and Area Served
 Table 22. Global Key Players of Antiserum, Products and Applications
 Table 23. Global Key Players of Antiserum, Date of General Availability (GA)
 Table 24. Mergers and Acquisitions, Expansion Plans
 Table 25. Global Antiserum Market Size by Type (US$ Million), 2021–2026
 Table 26. Global Antiserum Revenue Market Share by Type (2021–2026)
 Table 27. Global Antiserum Forecasted Market Size by Type (US$ Million), 2027–2032
 Table 28. Global Antiserum Revenue Market Share by Type (2027–2032)
 Table 29. Global Antiserum Market Size by Application (US$ Million), 2021–2026
 Table 30. Global Antiserum Revenue Market Share by Application (2021–2026)
 Table 31. Global Antiserum Forecasted Market Size by Application (US$ Million), 2027–2032
 Table 32. Global Antiserum Revenue Market Share by Application (2027–2032)
 Table 33. North America Antiserum Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 34. North America Antiserum Market Size by Country (US$ Million), 2021–2026
 Table 35. North America Antiserum Market Size by Country (US$ Million), 2027–2032
 Table 36. Europe Antiserum Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 37. Europe Antiserum Market Size by Country (US$ Million), 2021–2026
 Table 38. Europe Antiserum Market Size by Country (US$ Million), 2027–2032
 Table 39. Asia-Pacific Antiserum Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 40. Asia-Pacific Antiserum Market Size by Region (US$ Million), 2021–2026
 Table 41. Asia-Pacific Antiserum Market Size by Region (US$ Million), 2027–2032
 Table 42. Latin America Antiserum Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 43. Latin America Antiserum Market Size by Country (US$ Million), 2021–2026
 Table 44. Latin America Antiserum Market Size by Country (US$ Million), 2027–2032
 Table 45. Middle East & Africa Antiserum Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 46. Middle East & Africa Antiserum Market Size by Country (US$ Million), 2021–2026
 Table 47. Middle East & Africa Antiserum Market Size by Country (US$ Million), 2027–2032
 Table 48. CSL Company Details
 Table 49. CSL Business Overview
 Table 50. CSL Antiserum Product
 Table 51. CSL Revenue in Antiserum Business (US$ Million), 2021–2026
 Table 52. CSL Recent Development
 Table 53. Merck Company Details
 Table 54. Merck Business Overview
 Table 55. Merck Antiserum Product
 Table 56. Merck Revenue in Antiserum Business (US$ Million), 2021–2026
 Table 57. Merck Recent Development
 Table 58. BTG Company Details
 Table 59. BTG Business Overview
 Table 60. BTG Antiserum Product
 Table 61. BTG Revenue in Antiserum Business (US$ Million), 2021–2026
 Table 62. BTG Recent Development
 Table 63. Pfizer Company Details
 Table 64. Pfizer Business Overview
 Table 65. Pfizer Antiserum Product
 Table 66. Pfizer Revenue in Antiserum Business (US$ Million), 2021–2026
 Table 67. Pfizer Recent Development
 Table 68. CNBG Company Details
 Table 69. CNBG Business Overview
 Table 70. CNBG Antiserum Product
 Table 71. CNBG Revenue in Antiserum Business (US$ Million), 2021–2026
 Table 72. CNBG Recent Development
 Table 73. Bharat Serums and Vaccines Company Details
 Table 74. Bharat Serums and Vaccines Business Overview
 Table 75. Bharat Serums and Vaccines Antiserum Product
 Table 76. Bharat Serums and Vaccines Revenue in Antiserum Business (US$ Million), 2021–2026
 Table 77. Bharat Serums and Vaccines Recent Development
 Table 78. Haffkine Bio-Pharmaceutical Company Details
 Table 79. Haffkine Bio-Pharmaceutical Business Overview
 Table 80. Haffkine Bio-Pharmaceutical Antiserum Product
 Table 81. Haffkine Bio-Pharmaceutical Revenue in Antiserum Business (US$ Million), 2021–2026
 Table 82. Haffkine Bio-Pharmaceutical Recent Development
 Table 83. Serum Biotech Company Details
 Table 84. Serum Biotech Business Overview
 Table 85. Serum Biotech Antiserum Product
 Table 86. Serum Biotech Revenue in Antiserum Business (US$ Million), 2021–2026
 Table 87. Serum Biotech Recent Development
 Table 88. Bio-Rad Company Details
 Table 89. Bio-Rad Business Overview
 Table 90. Bio-Rad Antiserum Product
 Table 91. Bio-Rad Revenue in Antiserum Business (US$ Million), 2021–2026
 Table 92. Bio-Rad Recent Development
 Table 93. BD Company Details
 Table 94. BD Business Overview
 Table 95. BD Antiserum Product
 Table 96. BD Revenue in Antiserum Business (US$ Million), 2021–2026
 Table 97. BD Recent Development
 Table 98. Vins Bioproducts Company Details
 Table 99. Vins Bioproducts Business Overview
 Table 100. Vins Bioproducts Antiserum Product
 Table 101. Vins Bioproducts Revenue in Antiserum Business (US$ Million), 2021–2026
 Table 102. Vins Bioproducts Recent Development
 Table 103. FUJIFILM Wako Pure Chemical Corporation Company Details
 Table 104. FUJIFILM Wako Pure Chemical Corporation Business Overview
 Table 105. FUJIFILM Wako Pure Chemical Corporation Antiserum Product
 Table 106. FUJIFILM Wako Pure Chemical Corporation Revenue in Antiserum Business (US$ Million), 2021–2026
 Table 107. FUJIFILM Wako Pure Chemical Corporation Recent Development
 Table 108. SSI Diagnostica Company Details
 Table 109. SSI Diagnostica Business Overview
 Table 110. SSI Diagnostica Antiserum Product
 Table 111. SSI Diagnostica Revenue in Antiserum Business (US$ Million), 2021–2026
 Table 112. SSI Diagnostica Recent Development
 Table 113. GD Animal Health Company Details
 Table 114. GD Animal Health Business Overview
 Table 115. GD Animal Health Antiserum Product
 Table 116. GD Animal Health Revenue in Antiserum Business (US$ Million), 2021–2026
 Table 117. GD Animal Health Recent Development
 Table 118. Research Programs/Design for This Report
 Table 119. Key Data Information from Secondary Sources
 Table 120. Key Data Information from Primary Sources
 Table 121. Authors List of This Report


List of Figures
 Figure 1. Antiserum Picture
 Figure 2. Global Antiserum Market Size Comparison by Type (US$ Million), 2021–2032
 Figure 3. Global Antiserum Market Share by Type: 2025 vs 2032
 Figure 4. Antitoxin Serum Features
 Figure 5. Antibacterial Serum Features
 Figure 6. Antiviral Serum Features
 Figure 7. Others Features
 Figure 8. Global Antiserum Market Size by Application (US$ Million), 2021–2032
 Figure 9. Global Antiserum Market Share by Application: 2025 vs 2032
 Figure 10. Clinical Case Studies
 Figure 11. Laboratory Case Studies
 Figure 12. Antiserum Report Years Considered
 Figure 13. Global Antiserum Market Size (US$ Million), Year-over-Year: 2021–2032
 Figure 14. Global Antiserum Market Size, (US$ Million), 2021 vs 2025 vs 2032
 Figure 15. Global Antiserum Market Share by Region: 2025 vs 2032
 Figure 16. Global Antiserum Market Share by Players in 2025
 Figure 17. Global Antiserum Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
 Figure 18. The Top 10 and 5 Players Market Share by Antiserum Revenue in 2025
 Figure 19. North America Antiserum Market Size YoY Growth (US$ Million), 2021–2032
 Figure 20. North America Antiserum Market Share by Country (2021–2032)
 Figure 21. United States Antiserum Market Size YoY Growth (US$ Million), 2021–2032
 Figure 22. Canada Antiserum Market Size YoY Growth (US$ Million), 2021–2032
 Figure 23. Europe Antiserum Market Size YoY Growth (US$ Million), 2021–2032
 Figure 24. Europe Antiserum Market Share by Country (2021–2032)
 Figure 25. Germany Antiserum Market Size YoY Growth (US$ Million), 2021–2032
 Figure 26. France Antiserum Market Size YoY Growth (US$ Million), 2021–2032
 Figure 27. U.K. Antiserum Market Size YoY Growth (US$ Million), 2021–2032
 Figure 28. Italy Antiserum Market Size YoY Growth (US$ Million), 2021–2032
 Figure 29. Russia Antiserum Market Size YoY Growth (US$ Million), 2021–2032
 Figure 30. Ireland Antiserum Market Size YoY Growth (US$ Million), 2021–2032
 Figure 31. Asia-Pacific Antiserum Market Size YoY Growth (US$ Million), 2021–2032
 Figure 32. Asia-Pacific Antiserum Market Share by Region (2021–2032)
 Figure 33. China Antiserum Market Size YoY Growth (US$ Million), 2021–2032
 Figure 34. Japan Antiserum Market Size YoY Growth (US$ Million), 2021–2032
 Figure 35. South Korea Antiserum Market Size YoY Growth (US$ Million), 2021–2032
 Figure 36. Southeast Asia Antiserum Market Size YoY Growth (US$ Million), 2021–2032
 Figure 37. India Antiserum Market Size YoY Growth (US$ Million), 2021–2032
 Figure 38. Australia & New Zealand Antiserum Market Size YoY Growth (US$ Million), 2021–2032
 Figure 39. Latin America Antiserum Market Size YoY Growth (US$ Million), 2021–2032
 Figure 40. Latin America Antiserum Market Share by Country (2021–2032)
 Figure 41. Mexico Antiserum Market Size YoY Growth (US$ Million), 2021–2032
 Figure 42. Brazil Antiserum Market Size YoY Growth (US$ Million), 2021–2032
 Figure 43. Middle East & Africa Antiserum Market Size YoY Growth (US$ Million), 2021–2032
 Figure 44. Middle East & Africa Antiserum Market Share by Country (2021–2032)
 Figure 45. Israel Antiserum Market Size YoY Growth (US$ Million), 2021–2032
 Figure 46. Saudi Arabia Antiserum Market Size YoY Growth (US$ Million), 2021–2032
 Figure 47. UAE Antiserum Market Size YoY Growth (US$ Million), 2021–2032
 Figure 48. CSL Revenue Growth Rate in Antiserum Business (2021–2026)
 Figure 49. Merck Revenue Growth Rate in Antiserum Business (2021–2026)
 Figure 50. BTG Revenue Growth Rate in Antiserum Business (2021–2026)
 Figure 51. Pfizer Revenue Growth Rate in Antiserum Business (2021–2026)
 Figure 52. CNBG Revenue Growth Rate in Antiserum Business (2021–2026)
 Figure 53. Bharat Serums and Vaccines Revenue Growth Rate in Antiserum Business (2021–2026)
 Figure 54. Haffkine Bio-Pharmaceutical Revenue Growth Rate in Antiserum Business (2021–2026)
 Figure 55. Serum Biotech Revenue Growth Rate in Antiserum Business (2021–2026)
 Figure 56. Bio-Rad Revenue Growth Rate in Antiserum Business (2021–2026)
 Figure 57. BD Revenue Growth Rate in Antiserum Business (2021–2026)
 Figure 58. Vins Bioproducts Revenue Growth Rate in Antiserum Business (2021–2026)
 Figure 59. FUJIFILM Wako Pure Chemical Corporation Revenue Growth Rate in Antiserum Business (2021–2026)
 Figure 60. SSI Diagnostica Revenue Growth Rate in Antiserum Business (2021–2026)
 Figure 61. GD Animal Health Revenue Growth Rate in Antiserum Business (2021–2026)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SecuX Technology Inc